- Early access strategy development
Building Stronger Market Access Pathways for Medical Technology Companies
We help medical device manufacturers navigate payer expectations, reimbursement frameworks, and procurement systems with clear, implementation-focused strategy.
Fill The Information
Medical Device Market Access Services
Bringing a medical device to market requires more than regulatory clearance. Commercial success depends on pricing structure, reimbursement positioning, evidence strategy, and the ability to demonstrate measurable value to payers and procurement bodies. At WH Partners, our medical device market access services are designed to help manufacturers navigate complex healthcare systems with clarity and strategic focus.
We work with medical technology companies that require structured, practical guidance across the full market access journey. From early strategic planning to launch preparation and post-launch optimization, our approach emphasizes measurable outcomes, sustainable pricing, and long-term access stability. We provide Pricing and Reimbursement strategic advice to ensure your device achieves both regulatory and commercial success.
Strategic Medical Device Market Access Services for Sustainable Growth
Market access decisions made during product development can significantly shape commercial performance. Our approach begins well before market entry. We support companies in aligning clinical evidence, health economic data, and value communication strategies with payer and hospital expectations to strengthen reimbursement positioning.
Switzerland and broader European markets require tailored preparation. Each country operates under distinct procurement systems, reimbursement mechanisms, and hospital financing structures. We guide clients through these differences with structured analysis and practical Pricing and Reimbursement consultant guidance.
Our team supports:
From Development to Market Adoption and Beyond
Market access for medical technologies is not a one-time event. It is a continuous process that evolves with clinical data, policy shifts, and competitive dynamics. Our medical device market access services support manufacturers across three key phases:
01
Early Development Phase
During development, we assess clinical endpoints, comparator choices, and economic evidence plans to ensure alignment with payer and hospital decision criteria.
02
Pre-Launch Phase
In preparation for launch, we refine pricing structures, validate reimbursement pathways, prepare submission documentation, and support stakeholder engagement strategies. We stress test positioning and anticipate potential objections.
03
Post-Launch Optimization
After market entry, we monitor pricing performance, procurement outcomes, and policy developments. We support lifecycle strategies designed to strengthen and expand market access over time.
By maintaining strategic continuity across phases, we ensure that your access strategy remains coherent, adaptive, and commercially sustainable.
Ready to Move Forward
“Transform complex reimbursement challenges into structured commercial clarity.”
Schedule a ConsultationWhy Choose Us?
Choosing the right partner for medical technology market access is a strategic decision. WH Partners combines healthcare system expertise with practical implementation support, providing dedicated Pricing and Reimbursement consultant services across Swiss and European markets.
Specialized Expertise
We focus on healthcare and life sciences strategy, including complex device reimbursement environments. Our experience across Swiss and European systems allows us to provide realistic, actionable insight.
Senior Level Involvement
You work directly with experienced consultants who understand the nuances of Swiss and European healthcare systems. We stay actively involved throughout the engagement, ensuring consistency and quality.
Our recommendations are designed for implementation. We translate regulatory, economic, and clinical considerations into clear action steps your teams can execute effectively.
Tailored Solutions
Each device category and market context is different. We design customized strategies aligned with your timelines, internal capabilities, and commercial priorities.
Collaborative Approach
We work closely with cross functional teams to ensure alignment between regulatory, medical, commercial, and health economics functions. Clear communication and shared understanding drive stronger outcomes.
Long Term Perspective
Market access evolves with policy, innovation, and competitive pressure. We help build resilient strategies designed to sustain adoption and reimbursement over time.
While we have strong expertise in Switzerland, we also support broader European market access strategies.
You can contact us to schedule an initial consultation. We will discuss your objectives, timelines, and challenges before defining a tailored engagement plan.
A Structured Yet Flexible Consulting Model
As a specialized advisory firm in medical technology strategy, we recognize that every device, indication, and company structure presents unique challenges. Our methodology combines a clear analytical framework with flexibility to adapt across therapeutic areas, device classes, and organizational maturity levels.
We begin with a focused discovery session to understand your product profile, evidence base, target markets, and commercial objectives. These insights are translated into a practical roadmap with defined milestones, timelines, and responsibilities. Throughout the engagement, we collaborate closely with regulatory, clinical, commercial, and health economics teams to ensure alignment and transparent communication at every stage.
We prioritize:
A Long-Term Partnership Approach
Our support extends beyond individual submissions or launch projects. Many clients engage us as ongoing advisors throughout product development and commercialization. This continuity allows us to refine strategy as new data emerges and reimbursement landscapes evolve.
Through disciplined analysis and collaborative execution, we help transform complex access challenges into structured, manageable pathways for growth.
If you are preparing for market entry, expanding into Switzerland, or reassessing pricing and reimbursement strategy for an existing device portfolio, WH Partners provides experienced guidance tailored to your objectives.
Frequently Asked Questions
What makes medical device market access different from pharmaceuticals?
Medical devices often involve hospital procurement systems, DRG frameworks, and coding considerations in addition to reimbursement evaluation. This creates a distinct access pathway requiring a tailored strategy.
When should device manufacturers begin market access planning?
Ideally during early product development to ensure clinical and economic evidence generation aligns with payer and hospital expectations.
How does Swiss reimbursement for medical devices differ from the EU?
Switzerland operates under its own regulatory, pricing, and reimbursement structures, with specific procurement dynamics that differ from many EU member states.
What evidence supports medical device reimbursement approval?
Reimbursement typically requires clinical effectiveness data, safety outcomes, and economic justification such as cost impact or cost effectiveness analysis, depending on the market and device type.
What is included in a pricing strategy for medical devices?
Pricing strategy includes benchmark analysis, procurement structure evaluation, DRG impact assessment, scenario modeling, and risk mitigation planning.
Can you support coding and reimbursement submissions?
Yes. We assist with documentation structuring, economic justification, and stakeholder preparation to strengthen submission quality and negotiation outcomes.
Do you only focus on Switzerland?
While we have strong Swiss expertise, we also support broader European market access strategies.
How do we begin working with WH Partners?
You can contact us to schedule an initial consultation. We will discuss your objectives, timelines, and market priorities before defining a tailored engagement roadmap.
Schedule A Call.
Why Choose Us?
Trusted by 500+ satisfied customers with over 10+ years of experience in global healthcare markets.
Get in Touch
Fill out the form below and our team will get back to you shortly.